JEMGX
Price
$9.19
Change
-$0.18 (-1.92%)
Updated
Sep 6 closing price
VEIEX
Price
$27.63
Change
-$0.39 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

JEMGX vs VEIEX

Header iconJEMGX vs VEIEX Comparison
Open Charts JEMGX vs VEIEXBanner chart's image
JHancock Emerging Markets Equity R6
Price$9.19
Change-$0.18 (-1.92%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$27.63
Change-$0.39 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JEMGX vs VEIEX Comparison Chart
Loading...
VS
JEMGX vs. VEIEX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEMGX is a Buy and VEIEX is a Buy.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 108B vs. JEMGX (1.42B). VEIEX pays higher dividends than JEMGX: VEIEX (3.27) vs JEMGX (1.63). JEMGX was incepted earlier than VEIEX: JEMGX (9 years) vs VEIEX (30 years). JEMGX is a more actively managed with annual turnover of: 37.00 vs. VEIEX (5.00). VEIEX has a lower initial minimum investment than JEMGX: VEIEX (0) vs JEMGX (1000000). VEIEX annual gain was more profitable for investors over the last year : 11.44 vs. JEMGX (7.68). VEIEX return over 5 years is better than : 16.99 vs. JEMGX (-6.95).
JEMGXVEIEXJEMGX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years30 years-
Gain YTD3.7657.87748%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B108B1%
Annual Yield % from dividends1.633.2750%
Returns for 1 year7.6811.4467%
Returns for 3 years-36.83-10.67345%
Returns for 5 years-6.9516.99-41%
Returns for 10 yearsN/A12.90-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATS25.550.42
+1.67%
ATS Corp
VRSN183.56-1.33
-0.72%
VeriSign
AMTB20.98-0.24
-1.13%
Amerant Bancorp
TLYS4.75-0.19
-3.85%
Tilly's
MIRA1.58-0.12
-7.06%
MIRA Pharmaceuticals